Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
株式のランク #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
株価
$8.92
最終同期: 2024-10-18
時価総額
$674.03M
変化(1日)
-5.14%
変化(1年)
0.00%
KR
取引 Jeisys Medical Inc. (287410)

カテゴリー

Jeisys Medical Inc.(287410)の営業利益率
August 2026 時点の営業利益率 TTM: 25.39%
Jeisys Medical Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は 25.39% です。2022 年末時点では 29.20% でした。
Jeisys Medical Inc. の営業利益率の履歴(2019 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) 25.39% 0.00%
2023 25.39% -13.05%
2022 29.20% 0.55%
2021 29.04% 25.93%
2020 23.06% 0.00%
2019 0.00% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.03% -99.33%
US
22.03% -99.13%
US
17.86% -99.30%
IE
21.46% -99.15%
US
0.00% -
DE
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。